The hugely successful Euro-Africa Health Investment Conference (EAHIC) was the first event of its kind in Europe focusing on the African pharmaceutical industry.
From manufacturing and distribution of drugs, to medical technologies, pharmaceutics and life sciences, new investments are required to meet growing healthcare needs in Africa and these are topics of daily interest impacting many countries on the continent in ensuring equitable access to medicines for curative and preventive healthcare.
In addition to highlighting and showcasing the opportunities for investment in the pharmaceutical sector across Sub Saharan Africa, the 1st EAHIC sought to increase awareness on how to facilitate and enhance Africa’s pharmaceutical capability and capacity to address healthcare needs, contribute to the employment agenda as well as promote collaboration in Africa’s nascent local pharmaceutical manufacturing industry within the public and private sectors.
EAHIC was held over two days, March 26-27, 2013 at the Institute of Physics, 76 Portland Place, in London, United Kingdom.
The inaugural EAHIC saw industry executives, policy makers, investors, project developers and key stakeholders converge to identify and discuss the latest investment opportunities in the nascent and exciting local pharmaceutical manufacturing sector, public-private cooperation opportunities and pharmaceutical innovation to improve access to medicines and contribute to sustainable development of healthcare systems across Sub-Saharan Africa. EAHIC was a gathering of stakeholders who are committed to improving access to essential, quality and efficacious medicines and promoting the growth of a strong Africa perspective in the pharma arena.